Benzinga | Nov 9, 2021 05:48PM EST

Inozyme Pharma Q3 EPS $(0.60) Up From $(1.55) YoY

Inozyme Pharma (NASDAQ:INZY) reported quarterly losses of $(0.60) per share. This is a 61.29 percent increase over losses of $(1.55) per share from the same period last year.